Solugen

Solugen is a specialty chemicals company that applies industrial biotechnology and green chemistry principles to re-design the production of a variety of end-use and novel chemicals.

Solugen's mission is to help the fight against climate change by creating cleaner, greener, and safer chemical processes that reduce reliance on non-renewable resources and energy-intensive manufacturing, without sacrificing safety and efficacy.

Solugen was founded in 2016 by Gaurab Chakrabarti and Sean Hunt. The company is headquartered in Houston, Texas, with an office in Slaton, Texas.

 

Solugen's first product, BioPeroxide™, was created using patented enzymatic technology to convert plant sugars into hydrogen peroxide and was followed by the manufacturing of a comprehensive line of products such as their flagship ScaleSol™ and BioChelate™ solutions.

 

Solugen’s patented Bioforge processes produce chemicals from bio-based feedstocks and are based on breakthroughs in synthetic biology, metal catalyst engineering, and modular plant design.

 

Solugen’s solutions remove the need for highly combustible and toxic petrochemical-based chemicals to clean water as its products are more efficacious, cheaper, safer to produce, and less hazardous for customers and their employees as well as fully biodegradable.

 

Solugen is backed by GIC, Baillie Gifford, Temasek, Founders Fund, BlackRock, Kennivik, Lowercarbon Capital, Carbon Direct Capital Management, Refactor Capital, Y Combinator, and others. The company raised $200M in Series D round on Oct 28, 2022. This brings Solugen's total funding to $635.2M to date. The latest round pushed the company's valuation to over $2B, up from previous $1.8B in Sep 2021.

 

 

  • Year founded: 2016
  • Funding Info: $635.2M over 6 Rounds (Latest Funding Type: Series D)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: Valued at over $2B as of Oct 28, 2022
  • City/Town: Houston
  • State: Texas
  • Country: United States
Related businesses